Andractim (Androstanolone)

Androstanolone, the active ingredient in Andractim, acts as an androgen receptor agonist. It binds to intracellular androgen receptors and modulates gene transcription to exert androgenic and anabolic effects, helping to manage androgen deficiency and related conditions.

The usual dose of Andractim is determined by a healthcare professional based on the patient's condition. It is typically applied once daily to clean, dry skin, with the exact dosage and application area specified by the prescribing physician.

Andractim is contraindicated in women who are pregnant or breastfeeding. It should not be used by women, especially those who are pregnant or nursing, due to potential risks to the fetus or infant.

To order Andractim from GNH India, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams across international markets and will ask the buyer to confirm trade or institutional credentials. The team will then reply with pricing, availability, shipping, and the import paperwork.

Andractim is a topical gel containing dihydrotestosterone (DHT), which bypasses the liver and avoids conversion to estrogen. Unlike testosterone, DHT cannot be converted by the aromatase enzyme into estrogen, making it suitable for estrogen-sensitive conditions like gynecomastia.

Andractim should be stored at ambient temperature, away from children and pets. The tube should be kept in a safe place, and the gel should be applied to clean, dry skin. Avoid washing the application site for at least 6 hours after application.

Andractim is applied topically using the supplied dosing spatula to the area specified by the physician, commonly the chest or abdomen. The gel should be allowed to dry for 5 minutes before dressing, and hands should be washed thoroughly after application to prevent transfer to others.

The most serious risks associated with Andractim include prostate enlargement or cancer, increased risk of blood clots, liver toxicity, worsening of sleep apnea, and increased risk of heart disease. Regular monitoring and medical supervision are essential to manage these risks.

Andractim should not be used by women, especially those who are pregnant or breastfeeding. It is also contraindicated in men with a history of prostate or breast cancer. Individuals with known allergies to any of the ingredients should avoid using Andractim.